DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Jones D, Manns MP, Hexham M, Pedrosa MC, Vierling JM.
AMBER- a novel phase 2/3 trial of ianalumab, a human anti-BAFF receptor antibody, in autoimmune hepatitis, NCT03217422.
Hepatology 2018;
68: 1120A
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.